Dipharma Francis Srl
About Dipharma Francis Srl
Categories

-
IT
-
2015On CPHI since
-
250 - 499Employees
Company types
Meet us at
CPHI North America 2023
Pennsylvania Convention Center, Philadelphia
April 25 - 27, 2023
CPHI Barcelona 2023
Fira Barcelona Gran Via, Spain
24-26 October 2023
Products from Dipharma Francis Srl (5)
-
Product Bupropion Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Bupropion Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information. -
Product Fexofenadine Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Fexofenadine Hydrochloride. It belongs to commercial products category. Therapeutic category: Antihistaminic. Contact us for more information. -
Product Nortriptyline Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Nortriptyline Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information. -
Product Ursodeoxycholic Acid
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Ursodeoxycholic Acid. It belongs to commercial products category. Therapeutic category: Cholelitholytic Agent. Contact us for more information. -
Product Aminocaproic Acid*
Dipharma manufactures wide range of Active Pharmaceutical Ingredients which includes Aminocaproic Acid*. It belongs to new products category. Therapeutic category: Treatment of bleeding disorders. Contact us for more information.
* only for specific markets. See our web site
Dipharma Francis Srl Resources (2)
-
Sponsored Content Dipharma receives EcoVadis Silver Medal
"EcoVadis Silver Medal confirms the quality of Dipharma’s sustainability approach and allows our customers to partner with us in continuing the journey toward more sustainable development". -
News Dipharma’s cGMP Pilot plant, expansion proceeding according to plan
With an investment of €2.7 Million, the company continues to consolidate its position to be among the leading small molecule CDMOs. The new production line doubles the capacity of the existing pilot plant.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance